Health Canada - Note to editors

    OTTAWA, April 10 /CNW Telbec/ - Health Canada today released the
April 2007 issue of the Canadian Adverse Reaction Newsletter (CARN),
containing the annual adverse reaction reporting statistics for calendar year
2006. This edition also features an article on the antipsychotic drug
quetiapine, and its suspected association with inflammation of the pancreas
and a low platelet count in the blood.
    Other topics covered include an update on cardiovascular adverse
reactions related to bitter orange (synephrine), which is used in a variety of
natural health products promoted for weight loss; and a case presentation on
telithromycin, a drug used to treat respiratory tract infections, and its
suspected association with a serious skin disorder.
    The newsletter also presents a quarterly summary of health professional
and consumer advisories.
    The April edition of CARN can be viewed on the Health Canada Web site at:

For further information:

For further information: Media Inquiries: Alastair Sinclair, Health
Canada, (613) 957-1803

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890